Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Venetoclax-Based Salvage Therapy Improves Outcome in Relapsed/Refractory AML Patients Eligible for Intensive Treatment: A Propensity Score Matching Analysis

Blood (2022) 140 (Supplement 1): 3317–3319.

https://doi.org/10.1182/blood-2022-167677

Published: 2022

Journal Articles

Intensified Cytarabine Dose during Consolidation Therapy in AML Patients Under 65 Years Is Not Associated with Survival Benefit

Blood (2021) 138 (Supplement 1): 1242.

https://doi.org/10.1182/blood-2021-146606

Published: 2021

Journal Articles

Characteristics and Outcome of Patients with Acute Myeloid Leukemia and Trisomy 4

Blood (2021) 138 (Supplement 1): 1307.

https://doi.org/10.1182/blood-2021-150281

Published: 2021

Journal Articles

Venetoclax-Azacitidine As Salvage Therapy and Bridge to Allogeneic Cell Transplantation in Relapsed/Refractory AML Compared to Historical Data of the SAL Registry Study

Blood (2021) 138 (Supplement 1): 4418.

https://doi.org/10.1182/blood-2021-151287

Published: 2021

Journal Articles

Mono/oligoclonal T and NK cells are common in chronic myeloid leukemia patients at diagnosis and expand during dasatinib therapy

Anna Kreutzman, Vesa Juvonen, Veli Kairisto, Marja Ekblom, Leif Stenke, Ruth Seggewiss, Kimmo Porkka, Satu Mustjoki

Blood (2010) 116 (5): 772–782.

https://doi.org/10.1182/blood-2009-12-256800

Published: 2010

Journal Articles

Immune reconstitution after allogeneic transplantation and expanding options for immunomodulation: an update

Ruth Seggewiss, Hermann Einsele

Blood (2010) 115 (19): 3861–3868.

https://doi.org/10.1182/blood-2009-12-234096

Published: 2010

Journal Articles

Mono/Oligoclonal T and NK Cells Are Common in Philadelphia Chromosome Positive (Ph+) Leukemia Patients at Diagnosis and Expand During Successful Tyrosine Kinase Inhibitor Therapy.

Anna Kreutzman, MSc, Vesa Juvonen, PhD, Veli Kairisto, MD, PhD, Marja Ekblom, MD, PhD, Leif Stenke, MD, PhD, Ruth Seggewiss, MD, Kimmo Porkka, MD, PhD, Satu Mustjoki, MD, PhD

Blood (2009) 114 (22): 856.

https://doi.org/10.1182/blood.V114.22.856.856

Published: 2009

Journal Articles

Large Granular Lymphocyte (LGL) Expansions Comprising Oligoclonal T Cell or NK Cell Populations in Dasatinib Treated Patients Are Associated with HLA-A*0201, CMV Reactivation and Enhanced Anti-Leukemic Control.

Satu Mustjoki, MD, PhD, Anna Kreutzman, MSc, Carolin Dix, David A Price, MRCP, DPhil, Kristin Ladell, MD, Marja Ekblom, MD, PhD, Leif Stenke, MD, PhD, Hermann Einsele, MD, Kimmo Porkka, MD, PhD, Ruth Seggewiss, MD

Blood (2009) 114 (22): 1123.

https://doi.org/10.1182/blood.V114.22.1123.1123

Published: 2009

Journal Articles

Combining Established and Novel Immunomodulators: Synergistic Inhibition of Major T Cell Effector Functions by Dexamethasone and Dasatinib

Ruth Seggewiss, Carolin Dix, Hermann Einsele, MD

Blood (2008) 112 (11): 2564.

https://doi.org/10.1182/blood.V112.11.2564.2564

Published: 2008

Journal Articles

Profound Shut-Down of Antigen Specific T-Cell Effector Functions by Dasatinib.

Ralf Weichsel, Carolin Dix, Linda Wooldrige, BVSc MSc DPhil MRCVS, Matthew Clement, BSc, Angharad Fenton-May, DPhil, Josef Zezula, PhD, Elisabeth Greiner, PhD, Emma Gostick, BSc MSc, David A. Price, MD DPhil, Hermann Einsele, MD, Ruth Seggewiss, MD

Blood (2007) 110 (11): 1348.

https://doi.org/10.1182/blood.V110.11.1348.1348

Published: 2007

Journal Articles

Hematopoietic stem-cell behavior in nonhuman primates

Bryan E. Shepherd, Hans-Peter Kiem, Peter M. Lansdorp, Cynthia E. Dunbar, Geraldine Aubert, Andre LaRochelle, Ruth Seggewiss, Peter Guttorp, Janis L. Abkowitz

Blood (2007) 110 (6): 1806–1813.

https://doi.org/10.1182/blood-2007-02-075382

Published: 2007

Journal Articles

Keratinocyte growth factor augments immune reconstitution after autologous hematopoietic progenitor cell transplantation in rhesus macaques.

Ruth Seggewiss, Karin Loré, F. Javier Guenaga, Stefania Pittaluga, Joseph Mattapallil, Catherine K. Chow, Richard A. Koup, Kevin Camphausen, Martha C. Nason, Martin Meier-Schellersheim, Robert E. Donahue, Bruce R. Blazar, Cynthia E. Dunbar, Daniel C. Douek

Blood (2007) 110 (1): 441–449.

https://doi.org/10.1182/blood-2006-12-065623

Published: 2007

Includes: Supplemental data

Journal Articles

Acute myeloid leukemia is associated with retroviral gene transfer to hematopoietic progenitor cells in a rhesus macaque

Ruth Seggewiss, Stefania Pittaluga, Rima L. Adler, F. Javier Guenaga, Cole Ferguson, Ingo H. Pilz, Byoung Ryu, Brian P. Sorrentino, W. Scott Young, III, Robert E. Donahue, Christof von Kalle, Arthur W. Nienhuis, Cynthia E. Dunbar

Blood (2006) 107 (10): 3865–3867.

https://doi.org/10.1182/blood-2005-10-4108

Published: 2006

Includes: Supplemental data

Journal Articles

Keratinocyte Growth Factor Increases Thymic Output of Naïve T-Cells after Total Body Irradiation and Autologous Peripheral Blood Progenitor Cell Transplantation in Rhesus Macaques.

Ruth Seggewiss, MD, Karin Lore, PhD, F. Javier Guenaga, BS, Stefania Pittaluga, MD, Joseph J. Matappallil, PhD, David Ambrozak, PhD, Robert T. Bailer, Richard A. Koup, MD, Robert E. Donahue, DVM, Bruce R. Blazar, MD, Georg A. Hollander, MD, Daniel C. Douek, PhD, Cynthia E. Dunbar, MD

Blood (2005) 106 (11): 187.

https://doi.org/10.1182/blood.V106.11.187.187

Published: 2005

Journal Articles

Estimating the Replication Rate of Hematopoietic Stem Cells in Non-Human Primates: A Test of Hayflick’s Hypothesis.

Bryan E. Shepherd, Hans-Peter Kiem, MD, Cynthia E. Dunbar, MD, Andre Larochelle, MD, PhD, Robert E. Donahue, DVM, Ruth Seggewiss, MD, Peter M. Lansdorp, MD, PhD, Peter Guttorp, PhD, Janis L. Abkowitz, MD

Blood (2005) 106 (11): 1710.

https://doi.org/10.1182/blood.V106.11.1710.1710

Published: 2005

Journal Articles

Old before its time: age-related thymic dysfunction may preclude efficacy of gene therapy in older SCID-X1 patients

Ruth Seggewiss, Cynthia E. Dunbar

Blood (2005) 105 (11): 4160–4161.

https://doi.org/10.1182/blood-2005-03-1008

Published: 2005

Journal Articles

Imatinib inhibits T-cell receptor–mediated T-cell proliferation and activation in a dose-dependent manner

Ruth Seggewiss, Karin Loré, Elisabeth Greiner, Magnus K. Magnusson, David A. Price, Daniel C. Douek, Cynthia E. Dunbar, Adrian Wiestner

Blood (2005) 105 (6): 2473–2479.

https://doi.org/10.1182/blood-2004-07-2527

Published: 2005

Journal Articles

In Vitro Culture during Retroviral Transduction Improves Thymic Repopulation and Output after TBI and Autologous PBPC Transplantation in Rhesus Macaques.

Ruth Seggewiss, MD, Karin Lore, PhD, Javier F. Guenaga, Stefania Pittaluga, MD PhD, Mark E. Metzger, Allen Krouse, Robert E. Donahue, VMD, David Ambrozak, Daniel C. Douek, MD PhD, Cynthia E. Dunbar, MD

Blood (2004) 104 (11): 1196.

https://doi.org/10.1182/blood.V104.11.1196.1196

Published: 2004

Journal Articles

Proliferation of CD8 + T-Cells Specific for CMV and EBV in Response to TCR Mediated Recognition of Cognate Antigen Is Inhibited by Imatinib in a Dose-Dependent Manner.

Ruth Seggewiss, MD, Karin Lore, PhD, Elisabeth Greiner, PhD, Magnus K. Magnusson, MD, David A. Price, MD PhD, Daniel C. Douek, MD PhD, Cynthia E. Dunbar, MD, Adrian Wiestner, MD PhD

Blood (2004) 104 (11): 1342.

https://doi.org/10.1182/blood.V104.11.1342.1342

Published: 2004

Journal Articles

The impact of low-dose busulfan on clonal dynamics in nonhuman primates

Ken Kuramoto, Dean Follman, Peiman Hematti, Stephanie Sellers, Mikko O. Laukkanen, Ruth Seggewiss, Mark E. Metzger, Allen Krouse, Robert E. Donahue, Christof von Kalle, Cynthia E. Dunbar

Blood (2004) 104 (5): 1273–1280.

https://doi.org/10.1182/blood-2003-08-2935

Published: 2004

NARROW

Venetoclax-Based Salvage Therapy Improves Outcome in Relapsed/Refractory AML Patients Eligible for Intensive Treatment: A Propensity Score Matching Analysis

Intensified Cytarabine Dose during Consolidation Therapy in AML Patients Under 65 Years Is Not Associated with Survival Benefit

Characteristics and Outcome of Patients with Acute Myeloid Leukemia and Trisomy 4

Venetoclax-Azacitidine As Salvage Therapy and Bridge to Allogeneic Cell Transplantation in Relapsed/Refractory AML Compared to Historical Data of the SAL Registry Study

Mono/oligoclonal T and NK cells are common in chronic myeloid leukemia patients at diagnosis and expand during dasatinib therapy

Immune reconstitution after allogeneic transplantation and expanding options for immunomodulation: an update

Mono/Oligoclonal T and NK Cells Are Common in Philadelphia Chromosome Positive (Ph+) Leukemia Patients at Diagnosis and Expand During Successful Tyrosine Kinase Inhibitor Therapy.

Large Granular Lymphocyte (LGL) Expansions Comprising Oligoclonal T Cell or NK Cell Populations in Dasatinib Treated Patients Are Associated with HLA-A*0201, CMV Reactivation and Enhanced Anti-Leukemic Control.

Combining Established and Novel Immunomodulators: Synergistic Inhibition of Major T Cell Effector Functions by Dexamethasone and Dasatinib

Profound Shut-Down of Antigen Specific T-Cell Effector Functions by Dasatinib.

Hematopoietic stem-cell behavior in nonhuman primates

Keratinocyte growth factor augments immune reconstitution after autologous hematopoietic progenitor cell transplantation in rhesus macaques.

Acute myeloid leukemia is associated with retroviral gene transfer to hematopoietic progenitor cells in a rhesus macaque

Keratinocyte Growth Factor Increases Thymic Output of Naïve T-Cells after Total Body Irradiation and Autologous Peripheral Blood Progenitor Cell Transplantation in Rhesus Macaques.

Estimating the Replication Rate of Hematopoietic Stem Cells in Non-Human Primates: A Test of Hayflick’s Hypothesis.

Old before its time: age-related thymic dysfunction may preclude efficacy of gene therapy in older SCID-X1 patients

Imatinib inhibits T-cell receptor–mediated T-cell proliferation and activation in a dose-dependent manner

In Vitro Culture during Retroviral Transduction Improves Thymic Repopulation and Output after TBI and Autologous PBPC Transplantation in Rhesus Macaques.

Proliferation of CD8 + T-Cells Specific for CMV and EBV in Response to TCR Mediated Recognition of Cognate Antigen Is Inhibited by Imatinib in a Dose-Dependent Manner.

The impact of low-dose busulfan on clonal dynamics in nonhuman primates

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only